Skip to main content

Proteomics and Genomics

  • Chapter
Neuroimmune Pharmacology

Successful completion of sequencing of the human genome showed considerably smaller number of genes (20,000 to 25,000 protein coding genes) (International Human Genome Sequencing Consortium. Lander ES, 2004) than expected and the number of proteins greatly exceeding the number of genes. This had a big impact on how we envision human and other proteomes and how we will approach proteomic and genomic analyses in the future. Isoforms, products of one gene modified by posttranslational modifications or alternative splicing, is only one part of complexity because function and biological role can also depend on cytoplasmic, subcellular compartments, and/or extracellular localization. Interactions with other proteins and nonproteinacious molecules add yet another layer of complexity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 159.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Rozek, W., Ciborowski, P.S. (2008). Proteomics and Genomics. In: Gendelman, H.E., Ikezu, T. (eds) Neuroimmune Pharmacology. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-72573-4_49

Download citation

Publish with us

Policies and ethics